|
| | Pancreatic adenocarcinoma + incidental liver metastases | Nonmetastasized pancreatic adenocarcinoma | P value |
|
| Pylorus preserving pancreaticoduodenectomy | 16 (73%) | 14 (64%) | |
| Whipple procedure | 1 (5%) | 3 (14%) | |
| Total pancreatectomy | 4 (18%) | 4 (18%) | |
| Distal pancreatectomy | 1 (5%) | 1 (5%) | |
| Liver directed therapy | 22 | 0 | |
| Enucleation | 15 (68%) | 0 | |
| Segmentectomy | 7 (32%) | 0 | |
| Mean operation time (minutes) | 330.2 | 349.3 | 0.243 |
| Median intraoperative blood loss (mL) | 750 | 700 | 0.333 |
| Surgical radicality | | | |
| R0 | 7 (32%) | 13 (59%) | |
| R1 | 10 (46%) | 7 (32%) | |
| R2 | 5 (23%) | 2 (9%) | |
| Positive lymph node status (pN1) | 18 (82%) | 20 (91%) | |
| T-Stage | | | |
| pT2 | 1 (5%) | 1 (5%) | |
| pT3 | 17 (77%) | 17 (77%) | |
| pT4 | 4 (18%) | 4 (18%) | |
|